USA – Arcascope, a Chantilly, VA-based healthcare technology company, raised $2.85M in Seed funding.
The round was led by Supermoon Capital, with participation from Inception Health, New Dominion Angels, AIoT Health, Inflect Health, the Accelerate Blue Fund, the Monroe Brown Seed Fund, and HealthX Ventures, and and other angel investors. The company intends to use the funds to accelerate the commercial rollout of its evidence-based offering for shift workers and their employers, while expanding into new application areas. Led by CEO Olivia Walch, Arcascope is a circadian rhythms technology company focused on solving the problem of circadian rhythms disruption caused by modern life. The platform leverages signals from wearable devices to help people reclaim control of their time by offering personalized behavioral recommendations and environmental integrations. The company is launching the platform, currently accessible through the smartphone app, Shift. 27/09/2022
